Genetic-testing company 23andMe will sell its data bank to drugmaker Regeneron for US$256 million ($397.5 million), after filing for bankruptcy earlier this year.

Israeli Prime Minister Benjamin Netanyahu said that the country plans to take over the entire Gaza strip, as part of Israel’s ...

Treasury yields rose and US stock futures fell alongside the US dollar due to concerns about US debt and rising deficits ...

The European Union and UK have reached a tentative agreement on defence and security, fisheries and youth mobility in ...

Australia could take a share of the global AI economy, argues ex-OpenAI board member Helen Toner, but it will take ...

The Australian sharemarket ended the day lower, breaking an eight-day rally, as investors reacted to a downgrade in US credit ...

Shares in lithium miner Liontown Resources plunged on Monday after it told the market on Friday evening it couldn't explain a ...

Chinese industrial output and retail sales growth slowed last month as the world’s second-largest economy dealt with high ...

Utilities and airports software provider Gentrack is among the worst-performing ASX stock today despite posting higher ...

Little attention is paid to the trading arms of retail banks. Yet they have provided convenient cover at just the right time ...

Nvidia is in advanced negotiations to kick money into PsiQuantum's current funding round, according to The Information.

Three of the top 10 best-performing ASX 200 stocks were gold miners, buoyed by rising gold prices following a credit ...